ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity

NCT01507077 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: ZGN-440
DRUG: ZGN-440 sterile diluent

Sponsor

Zafgen, Inc.